GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSRX Industries Inc (OTCPK:GSRX) » Definitions » Beneish M-Score

GSRX Industries (GSRX Industries) Beneish M-Score : 0.00 (As of May. 17, 2024)


View and export this data going back to 2007. Start your Free Trial

What is GSRX Industries Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for GSRX Industries's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of GSRX Industries was 0.00. The lowest was 0.00. And the median was 0.00.


GSRX Industries Beneish M-Score Historical Data

The historical data trend for GSRX Industries's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSRX Industries Beneish M-Score Chart

GSRX Industries Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -13.50

GSRX Industries Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.96 -13.50 -12.50 -14.50 -5.92

Competitive Comparison of GSRX Industries's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, GSRX Industries's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSRX Industries's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSRX Industries's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where GSRX Industries's Beneish M-Score falls into.



GSRX Industries Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of GSRX Industries for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.1411+0.528 * 0.9412+0.404 * 0.4971+0.892 * 0.9445+0.115 * -1.1437
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.2493+4.679 * -0.391943-0.327 * 2.2803
=-5.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep20) TTM:Last Year (Sep19) TTM:
Total Receivables was $0.01 Mil.
Revenue was 2.746 + 2.602 + 2.839 + 1.942 = $10.13 Mil.
Gross Profit was 1.505 + 1.256 + 1.361 + 0.781 = $4.90 Mil.
Total Current Assets was $1.15 Mil.
Total Assets was $5.59 Mil.
Property, Plant and Equipment(Net PPE) was $3.05 Mil.
Depreciation, Depletion and Amortization(DDA) was $-0.20 Mil.
Selling, General, & Admin. Expense(SGA) was $6.90 Mil.
Total Current Liabilities was $1.91 Mil.
Long-Term Debt & Capital Lease Obligation was $1.09 Mil.
Net Income was -2.239 + 0.304 + 0.248 + -6.961 = $-8.65 Mil.
Non Operating Income was -0.429 + 0.046 + 0.045 + -6.439 = $-6.78 Mil.
Cash Flow from Operations was 0.503 + -0.051 + 0.104 + -0.238 = $0.32 Mil.
Total Receivables was $0.08 Mil.
Revenue was 2.757 + 3.439 + 2.866 + 1.662 = $10.72 Mil.
Gross Profit was 1.326 + 1.341 + 1.485 + 0.734 = $4.89 Mil.
Total Current Assets was $2.00 Mil.
Total Assets was $15.10 Mil.
Property, Plant and Equipment(Net PPE) was $5.58 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.49 Mil.
Selling, General, & Admin. Expense(SGA) was $29.29 Mil.
Total Current Liabilities was $1.30 Mil.
Long-Term Debt & Capital Lease Obligation was $2.26 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.01 / 10.129) / (0.075 / 10.724)
=0.000987 / 0.006994
=0.1411

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4.886 / 10.724) / (4.903 / 10.129)
=0.455614 / 0.484056
=0.9412

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1.15 + 3.051) / 5.585) / (1 - (1.997 + 5.575) / 15.098)
=0.247807 / 0.498477
=0.4971

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=10.129 / 10.724
=0.9445

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.492 / (0.492 + 5.575)) / (-0.202 / (-0.202 + 3.051))
=0.081094 / -0.070902
=-1.1437

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(6.899 / 10.129) / (29.294 / 10.724)
=0.681114 / 2.73163
=0.2493

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1.09 + 1.913) / 5.585) / ((2.258 + 1.302) / 15.098)
=0.53769 / 0.235793
=2.2803

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-8.648 - -6.777 - 0.318) / 5.585
=-0.391943

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

GSRX Industries has a M-score of -5.92 suggests that the company is unlikely to be a manipulator.


GSRX Industries Beneish M-Score Related Terms

Thank you for viewing the detailed overview of GSRX Industries's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


GSRX Industries (GSRX Industries) Business Description

Traded in Other Exchanges
N/A
Address
Building No. 3, int. Jose Efron Avenue, P.R. 606, Dorado, PRI, 00646
GSRX Industries Inc is a vertically integrated retail, production, and cultivation firm which provides unique medical and adult-use cannabis products. The dispensaries are located in Puerto Rico and California. The company generates revenue by selling medical cannabis, edibles, and paraphernalia, including, oils, lotions, THC pills, vaporizers, rigs, grinders, t-shirts, hats, logo items, and bongs and pipes with a vaporizer. Its geographical segments include California, Tennessee, Texas, and Puerto Rico, out of which a vast majority is generated from Puerto Rico.
Executives
Geoffrey Alison director, officer: President and Secretary 122 OCEAN PARK BLVD., SUITE 307, SANTA MONICA CA 90405
Fountainhead Capital Management Ltd 10 percent owner PORTMAN HOUSE HUE STREET, ST HELIER, JERSEY CHANNEL ISLANDS X0 JE45RP
Henry C. Casden director, officer: CEO 74090 EL PASEO SUITE 205 PALM DESERT CA 92260